Drug
Fomivirsen
Fomivirsen: highest development phase Phase 2, developed by Ionis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fomivirsen sodium NCT00002156 | Phase 2 | Cytomegalovirus Retinitis |
Latest
No recent events.
Follow Fomivirsen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.